Compare IMMX & BLMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | IMMX | BLMN |
|---|---|---|
| Founded | 2014 | 1988 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 629.3M | 709.7M |
| IPO Year | 2021 | 2012 |
| Metric | IMMX | BLMN |
|---|---|---|
| Price | $9.76 | $8.82 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 8 |
| Target Price | ★ $19.20 | $7.88 |
| AVG Volume (30 Days) | 1.5M | ★ 2.0M |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 4.99% |
| EPS Growth | N/A | ★ 106.71 |
| EPS | N/A | ★ 0.65 |
| Revenue | N/A | ★ $4,213,346,000.00 |
| Revenue This Year | N/A | $2.07 |
| Revenue Next Year | N/A | $1.81 |
| P/E Ratio | ★ N/A | $13.31 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.94 | $5.19 |
| 52 Week High | $11.61 | $10.70 |
| Indicator | IMMX | BLMN |
|---|---|---|
| Relative Strength Index (RSI) | 59.36 | 65.01 |
| Support Level | $7.99 | $7.03 |
| Resistance Level | $9.77 | N/A |
| Average True Range (ATR) | 0.74 | 0.46 |
| MACD | 0.20 | 0.08 |
| Stochastic Oscillator | 73.16 | 93.92 |
Immix Biopharma Inc is engaged in the discovery and development of novel cell therapies for hematologic malignancies (blood cancers) and other indications. It is a clinical-stage biopharmaceutical company developing a novel class of Tissue-Specific Therapeutics TM in oncology and inflammation. Its TME Normalization Technology allows drug candidates to circulate in the bloodstream, exit through tumor blood vessels and simultaneously attack all components of the TME. Its product candidates include CAR-T NXC-201 for autoimmune diseases, and IMX-110 for treatment of soft tissue sarcoma.
Bloomin Brands Inc is a casual dining restaurant company, with a portfolio of, differentiated restaurant concepts. Its restaurant portfolio includes Outback Steakhouse, Carrabba's Italian Grill, Bonefish Grill and Fleming's Prime Steakhouse & Wine Bar. Its restaurant concepts range in price point and degree of formality from casual (Outback Steakhouse and Carrabba's Italian Grill) to polished casual (Bonefish Grill) and fine dining (Fleming's Prime Steakhouse & Wine Bar). The U.S. segment includes all restaurants operating in the U.S. while franchised restaurants operating outside the U.S. are included in the international franchise segment.